Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2018

01-05-2018

Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study

Authors: Siavash Piran, Hugh Traquair, Noel Chan, Marlene Robinson, Sam Schulman

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2018

Login to get access

Abstract

Anticoagulant-related nephropathy is an acute kidney injury (AKI) associated with excessive anticoagulation. The nature of the association between excessive anticoagulation with warfarin and AKI and its incidence remain unclear. To evaluate the incidence of AKI in excessively anticoagulated patients taking warfarin and examine potential risk factors. A retrospective chart review was performed in patients on chronic warfarin. The primary outcome was AKI, defined as an acute increase in creatinine of > 26.5 µmol/L within 7–14 days of an international normalized ratio (INR) ≥ 4.0. 292 patients with an INR ≥ 4.0 were included. 101 patients had CKD and 191 did not have CKD. Of the 292 patients with an INR ≥ 4.0, 38 (13%) had an AKI. In univariable analyses, CKD [odds ratio (OR) 2.1, 95% confidence interval (CI) 0.99–4.43] and use of renin–angiotensin system (RAS) blockers and/or diuretics (OR 3.85; 95% CI 1.15–20.15) were significantly associated with the risk of AKI. In a binomial logistic regression model, use of RAS blockers and/or diuretics was the only significant predictor of AKI (OR 3.4; 95% CI 1.02–11.76). Use of RAS blockers and/or diuretics significantly increased the risk of AKI in patients with warfarin-related excessive anticoagulation. Further prospective studies examining the association of high INRs and AKI are needed.
Literature
1.
go back to reference Wheeler DS, Giugliano RP, Rangaswami J (2016) Anticoagulation-related nephropathy. J Thromb Haemost 14(3):461–467CrossRefPubMed Wheeler DS, Giugliano RP, Rangaswami J (2016) Anticoagulation-related nephropathy. J Thromb Haemost 14(3):461–467CrossRefPubMed
2.
go back to reference Brodsky SV, Hebert LA (2016) Anticoagulant-related nephropathy: is an AKI elephant hiding in plain view? J Am Coll Cardiol 68(21):2284–2286CrossRefPubMed Brodsky SV, Hebert LA (2016) Anticoagulant-related nephropathy: is an AKI elephant hiding in plain view? J Am Coll Cardiol 68(21):2284–2286CrossRefPubMed
3.
go back to reference Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW, Hamirani M, Hebert L, Calomeni E, Nadasdy T (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54(6):1121–1126CrossRefPubMed Brodsky SV, Satoskar A, Chen J, Nadasdy G, Eagen JW, Hamirani M, Hebert L, Calomeni E, Nadasdy T (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54(6):1121–1126CrossRefPubMed
4.
go back to reference Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM, Bhatt UY, Hebert LA (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181–189CrossRefPubMedPubMedCentral Brodsky SV, Nadasdy T, Rovin BH, Satoskar AA, Nadasdy GM, Wu HM, Bhatt UY, Hebert LA (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181–189CrossRefPubMedPubMedCentral
5.
go back to reference Woo KT, Lee GS, Foo MW, Chan CM (2012) Warfarin-related nephropathy in patients with chronic kidney disease. Kidney Int 82:113 (author reply 113–114)CrossRefPubMed Woo KT, Lee GS, Foo MW, Chan CM (2012) Warfarin-related nephropathy in patients with chronic kidney disease. Kidney Int 82:113 (author reply 113–114)CrossRefPubMed
6.
go back to reference Ware K, Brodsky P, Satoskar AA, Nadasdy T, Nadasdy G, Wu H, Rovin BH, Bhatt U, Von Visger J, Hebert LA, Brodsky SV (2011) Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 22(10):1856–1862CrossRefPubMedPubMedCentral Ware K, Brodsky P, Satoskar AA, Nadasdy T, Nadasdy G, Wu H, Rovin BH, Bhatt U, Von Visger J, Hebert LA, Brodsky SV (2011) Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 22(10):1856–1862CrossRefPubMedPubMedCentral
7.
go back to reference Ozcan A, Ware K, Calomeni E, Nadasdy T, Forbes R, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Brodsky SV (2012) 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35(4):356–364CrossRefPubMedPubMedCentral Ozcan A, Ware K, Calomeni E, Nadasdy T, Forbes R, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Brodsky SV (2012) 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35(4):356–364CrossRefPubMedPubMedCentral
8.
go back to reference Ware K, Qamri Z, Ozcan A, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Nadasdy T, Brodsky SV (2013) N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. Am J Nephrol 35(4):356–364 Ware K, Qamri Z, Ozcan A, Satoskar AA, Nadasdy G, Rovin BH, Hebert LA, Nadasdy T, Brodsky SV (2013) N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy. Am J Nephrol 35(4):356–364
9.
go back to reference Ryan M, Ware K, Qamri Z, Satoskar A, Wu H, Nadasdy G, Rovin B, Hebert L, Nadasdy T, Brodsky SV (2014) Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrol Dial Transplant 29(12):2228–2234CrossRefPubMed Ryan M, Ware K, Qamri Z, Satoskar A, Wu H, Nadasdy G, Rovin B, Hebert L, Nadasdy T, Brodsky SV (2014) Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats. Nephrol Dial Transplant 29(12):2228–2234CrossRefPubMed
10.
go back to reference Berger R, Salhanick SD, Chase M, Ganetsky M (2013) Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin. Ann Emerg Med 61(4):475–479CrossRefPubMed Berger R, Salhanick SD, Chase M, Ganetsky M (2013) Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin. Ann Emerg Med 61(4):475–479CrossRefPubMed
11.
go back to reference Rizk D, Warnock D (2011) Warfarin-related nephropathy: another newly recognized complication of an old drug. Kidney Int 80(2):131–133CrossRefPubMed Rizk D, Warnock D (2011) Warfarin-related nephropathy: another newly recognized complication of an old drug. Kidney Int 80(2):131–133CrossRefPubMed
12.
go back to reference Brodsky SV, Collins M, Park E, Rovin BH, Satoskar AA, Nadasdy G, Wu H, Bhatt U, Nadasdy T, Hebert LA (2010) Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115(2):c142–c146CrossRefPubMedPubMedCentral Brodsky SV, Collins M, Park E, Rovin BH, Satoskar AA, Nadasdy G, Wu H, Bhatt U, Nadasdy T, Hebert LA (2010) Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115(2):c142–c146CrossRefPubMedPubMedCentral
13.
go back to reference An JN, Ahn SY, Yoon CH, Youn TJ, Han MK, Kim S, Chin HJ, Na KY, Chae DW (2013) The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in Korean patients. PLoS ONE 8(4):e57661CrossRefPubMedPubMedCentral An JN, Ahn SY, Yoon CH, Youn TJ, Han MK, Kim S, Chin HJ, Na KY, Chae DW (2013) The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in Korean patients. PLoS ONE 8(4):e57661CrossRefPubMedPubMedCentral
14.
go back to reference Lim AK, Campbell DA (2013) Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation. Int Urol Nephrol 45(2):561–570CrossRefPubMed Lim AK, Campbell DA (2013) Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation. Int Urol Nephrol 45(2):561–570CrossRefPubMed
Metadata
Title
Incidence and risk factors for acute kidney injury in patients with excessive anticoagulation on warfarin: a retrospective study
Authors
Siavash Piran
Hugh Traquair
Noel Chan
Marlene Robinson
Sam Schulman
Publication date
01-05-2018
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1626-1

Other articles of this Issue 4/2018

Journal of Thrombosis and Thrombolysis 4/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.